These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 150083)

  • 1. MLC inhibitory alloantibodies and outcome of kidney allografts.
    Suciu-Foca N; Hardy M; Kiamar M; Weiner J; Susinno E; Molinaro AP; Jacob J; Reemtsma K
    Transplant Proc; 1978 Jun; 10(2):493-5. PubMed ID: 150083
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    Transplant Proc; 1978 Jun; 10(2):479-81. PubMed ID: 150082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in histocompatibility testing.
    Svejgaard A; Thomsen M
    Proc Eur Dial Transplant Assoc; 1976; 12():121-8. PubMed ID: 132660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts.
    Hardy M; Suciu-Foca N; McKiernan T; Rohowsky C; Cianci J; Jacob J; Pierce J; Reemtsma K
    Transplant Proc; 1979 Mar; 11(1):389-92. PubMed ID: 377661
    [No Abstract]   [Full Text] [Related]  

  • 5. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ; Harmer AW; Koffman CG; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract]   [Full Text] [Related]  

  • 6. Alloantibodies eluted from rejected human renal allografts: reactivity to primary kidney cells in culture.
    Mohanakumar T; Phibbs M; Haar J; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1980 Sep; 12(3 Suppl 1):65-68. PubMed ID: 7001704
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of anti-donor B lymphocyte antibodies in definitive allograft rejection.
    Soulillou JP; de Mouzon A; Peyrat MA; Guenel J
    Transplant Proc; 1979 Mar; 11(1):770-5. PubMed ID: 377710
    [No Abstract]   [Full Text] [Related]  

  • 8. A rapid MLC test for selection of allograft recipients for cadaveric kidneys.
    Butt KM; Parsa I; Kountz SL
    Surg Forum; 1973; 24():272-3. PubMed ID: 4282520
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
    Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
    Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants.
    Lazda VA; Jonasson O; Mozes MF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):949-52. PubMed ID: 6455829
    [No Abstract]   [Full Text] [Related]  

  • 12. Preexistent anti-HLA-DR antibodies and kidney graft survival.
    Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
    Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
    [No Abstract]   [Full Text] [Related]  

  • 13. MLC and HLA-DR typing: their relationship and relevance for transplantation.
    Cullen PR; Ting A; Morris PJ
    Transplant Proc; 1979 Mar; 11(1):756-9. PubMed ID: 156433
    [No Abstract]   [Full Text] [Related]  

  • 14. B-lymphocyte-specific antibodies in human renal allografts.
    Mohanakumar T; Giedlin M; DuVall C; Rhodes C; Phibbs M; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1979 Mar; 11(1):397-400. PubMed ID: 377664
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 16. MLC, PHA, HLA, and DRw studies in renal allografting.
    Braun WE; Jayavant M; Dejelo C; Zachary A; Novick A; Santos N; Williams T
    Transplant Proc; 1979 Dec; 11(4):1911-3. PubMed ID: 161103
    [No Abstract]   [Full Text] [Related]  

  • 17. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
    Hajek-Rosenmayr A; Wolf A
    Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between mixed lymphocyte culture in compatibility and cadaver kidney graft rejection.
    Thomsen M; Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):40-3. PubMed ID: 150639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy.
    Revillard JP; Robert M; DuPont E; Betuel H; Rifle G; Traeger J
    Transplant Proc; 1973 Mar; 5(1):331-5. PubMed ID: 4266656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.